US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
GB0325603D0
(en)
*
|
2003-11-03 |
2003-12-10 |
Sandoz Ag |
Organic compounds
|
WO2005070464A2
(en)
*
|
2004-01-21 |
2005-08-04 |
Biofarma Ilac Sanayi Ve Ticaret A.S. |
A tablet formulation of clopidogrel bisulphate
|
DE102004054054A1
(en)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Process for preparing chiral 8- (3-amino-piperidin-1-yl) -xanthines
|
KR20070009851A
(en)
*
|
2005-07-14 |
2007-01-19 |
씨제이 주식회사 |
Pharmaceutical compositions containing clopidogrel bisulfate
|
KR20070044323A
(en)
*
|
2005-10-24 |
2007-04-27 |
에스케이케미칼주식회사 |
Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate
|
IS2385B
(en)
*
|
2006-02-10 |
2008-07-15 |
Actavis Group Hf. |
Clopidogrel bisulfate pharmaceutical compositions
|
DE502006006787D1
(en)
|
2006-04-13 |
2010-06-02 |
Riemser Arzneimittel Ag |
Partial glycerides as lubricants for pharmaceutical compositions containing ThienoÄ3,2-cpyridine derivatives
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20080251A1
(en)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
USES OF DPP IV INHIBITORS
|
CN103951667A
(en)
|
2006-05-04 |
2014-07-30 |
勃林格殷格翰国际有限公司 |
Polymorphs
|
EP1900358A1
(en)
|
2006-09-16 |
2008-03-19 |
Cimex Pharma AG |
Pharmaceutical formulations comprising clopidogrel
|
CN100400035C
(en)
*
|
2006-10-18 |
2008-07-09 |
深圳信立泰药业股份有限公司 |
Clopidogrel sulfate solid preparation, and its preparing method
|
HUP0600839A3
(en)
*
|
2006-11-14 |
2008-09-29 |
Egis Gyogyszergyar Nyrt |
Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof
|
EP1970054A3
(en)
*
|
2007-03-14 |
2009-06-03 |
Ranbaxy Laboratories Limited |
Clopidogrel tablets
|
RU2009140792A
(en)
*
|
2007-04-09 |
2011-05-20 |
Юсв Лимитед (In) |
NEW STABLE PHARMACEUTICAL COMPOSITIONS BISULPHATE CLOPIDOGEL AND METHOD FOR PRODUCING THEM
|
KR20160033792A
(en)
|
2007-04-27 |
2016-03-28 |
사이덱스 파마슈티칼스, 인크. |
Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
|
PT2095815E
(en)
|
2008-02-26 |
2012-02-03 |
Lesvi Laboratorios Sl |
Pharmaceutical formulations containing clopidogrel
|
AR071175A1
(en)
|
2008-04-03 |
2010-06-02 |
Boehringer Ingelheim Int |
PHARMACEUTICAL COMPOSITION THAT INCLUDES AN INHIBITOR OF DIPEPTIDIL-PEPTIDASA-4 (DPP4) AND A COMPARING PHARMACO
|
US20090264460A1
(en)
*
|
2008-04-21 |
2009-10-22 |
Mamta Mishra |
Clopidogrel pharmaceutical formulations
|
ATE482961T1
(en)
|
2008-04-25 |
2010-10-15 |
Sandoz Ag |
HYDROGEN SULFATE OF 2-ACETOXY-5-(A-CYCLOPROPYLCARBONYL-2-FLUORBENZYL)-4,5,6,7-TETRAHYDROTHIENOÄ3,2-CUPYRIDINE AND PREPARATION THEREOF
|
BRPI0916997A2
(en)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
DPP-4 INHIBITOR AND ITS USE
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
US8865729B2
(en)
|
2008-12-23 |
2014-10-21 |
Boehringer Ingelheim International Gmbh |
Salt forms of a xanthine compound
|
PT3100728T
(en)
|
2009-05-13 |
2020-02-21 |
Cydex Pharmaceuticals Inc |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
AU2010323068B2
(en)
|
2009-11-27 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
|
CN101766573B
(en)
|
2010-02-05 |
2013-02-13 |
上海安必生制药技术有限公司 |
Preparation process of clopidogrel bisulfate solid preparation
|
EA033415B1
(en)
|
2010-05-05 |
2019-10-31 |
Boehringer Ingelheim Int |
Methods for treating obesity, use of dpp-4 inhibitor in these methods and method for treating patients suffering from type 2 diabetes mellitus
|
BR112012032579B1
(en)
|
2010-06-24 |
2021-05-11 |
Boehringer Ingelheim International Gmbh |
use of linagliptin and pharmaceutical composition comprising linagliptin and long-acting basal insulin
|
AR083878A1
(en)
|
2010-11-15 |
2013-03-27 |
Boehringer Ingelheim Int |
VASOPROTECTORA AND CARDIOPROTECTORA ANTIDIABETIC THERAPY, LINAGLIPTINA, TREATMENT METHOD
|
CN102309482B
(en)
*
|
2011-06-20 |
2013-04-10 |
海南良方医药有限公司 |
Clopidogrel hydrogensulfate composition and preparation method thereof
|
NZ618698A
(en)
|
2011-07-15 |
2015-08-28 |
Boehringer Ingelheim Int |
Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
JP6224084B2
(en)
|
2012-05-14 |
2017-11-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Xanthine derivatives as DPP-4 inhibitors for the treatment of glomerular epithelial cell related disorders and / or nephrotic syndrome
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
RU2540519C2
(en)
*
|
2013-02-05 |
2015-02-10 |
Общество с ограниченной ответственностью "Трейдсервис" |
Dosage form of clopidogrel
|
WO2015128453A1
(en)
|
2014-02-28 |
2015-09-03 |
Boehringer Ingelheim International Gmbh |
Medical use of a dpp-4 inhibitor
|
HUP1400294A2
(en)
|
2014-06-13 |
2015-12-28 |
Skillpharm Kft |
Novel application of clopidogrel
|
MX2018015089A
(en)
|
2016-06-10 |
2019-05-13 |
Boehringer Ingelheim Int |
Combinations of linagliptin and metformin.
|
CN106176644B
(en)
*
|
2016-08-18 |
2019-05-14 |
成都新柯力化工科技有限公司 |
A kind of clopidogrel sulfate solid tablet and preparation method thereof
|